DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Gout Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Gout Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Gout pipeline products, Gout epidemiology, Gout market valuations and forecast, Gout products sales and competitive landscape in the US.
The research is classified into nine sections - Gout overview including etiology, pathophysiology, and diagnosis, Gout treatment options, Gout pipeline products, Gout market analysis comprising of Gout epidemiology, key products marketed for Gout, market valuations and forecast, products sales and market shares.
Research Scope:
- Gout Pipeline: Find out the products in clinical trials for the treatment of Gout by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Gout Epidemiology: Find out the number of patients diagnosed (prevalence) with Gout in the US
- Gout Products: Identify key products marketed and prescribed for Gout in the US, including trade name, molecule name, and company
- Gout Product Sales: Find out the sales revenues of Gout products, both branded and generics, in the US
- Gout Market Valuations: Find out the market size for Gout products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Gout Products Market Share: Find out the market shares for key Gout products in the US
Key Topics Covered:
- Disease Overview
- Gout Treatments
- Gout Pipeline
- US Gout Epidemiology
- Marketed Drugs for Gout in US
- US Gout Market Size
- US Gout Products Sales
- US Gout Market Competitive Landscape
- US Gout Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/c52n3m/us_gout_market
